Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

f. hoffmann-la roche s.a. - pertuzumab - pertuzumab....420 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

aventis pharma limited - alemtuzumab - alemtuzumab....10.00mg

Australia - English - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - trastuzumab, quantity: 600 mg; water for injections, quantity: 15 ml; pertuzumab, quantity: 1200 mg - injection, solution - excipient ingredients: methionine; trehalose dihydrate; sucrose; histidine; histidine hydrochloride monohydrate; polysorbate 20; vorhyaluronidase alfa - early breast cancer (ebc),phesgo is indicated in combination with chemotherapy for the:,? neoadjuvant treatment of patients with her2-positive, locally advanced, inflammatory, or early stage breast cancer (either >2 cm in diameter or node positive) as part of a complete treatment regimen for early breast cancer,? adjuvant treatment of patients with her2-positive early breast cancer at high risk of recurrence,select patients for therapy based on a validated test.,metastatic breast cancer (mbc),phesgo is indicated in combination with docetaxel for patients with her2-positive metastatic or locally recurrent unresectable breast cancer, who have not received previous anti-her2 therapy or chemotherapy for their metastatic disease. select patients for therapy based on a validated test.

Kenya - English - Pharmacy and Poisons Board

f. hoffmann-la roche ltd grenzacherstrasse 124, ch-4070, basel, switzerland - pertuzumab and trastuzumab - solution for injection - one vial of 10 ml solution contains 600 mg of… - pertuzumab and trastuzumab

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - inotuzumab ozogamicin - powder, for solution - inotuzumab ozogamicin 1mg/vial

Canada - English - Health Canada

hoffmann-la roche limited - trastuzumab; pertuzumab - solution - 40mg; 80mg - trastuzumab 40mg; pertuzumab 80mg - antineoplastic agents

Canada - English - Health Canada

hoffmann-la roche limited - trastuzumab; pertuzumab - solution - 60mg; 60mg - trastuzumab 60mg; pertuzumab 60mg - antineoplastic agents

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

genzyme therapeutics ltd - alemtuzumab - solution for infusion - 10mg/1ml

Singapore - English - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - alemtuzumab - infusion, solution concentrate - alemtuzumab 12 mg/1.2 ml

European Union - English - EMA (European Medicines Agency)

wyeth europa ltd - gemtuzumab ozogamicin - leukemia, myeloid, acute - antineoplastic agents - re-induction treatment of cd33-positive aml adult patients in first relapse who are not candidates for other intensive re-induction chemotherapy regimens (e.g. high-dose ara-c) and meet at least one of the following criteria: duration of first remission 60 years.